Michael Thomas Henderson

Director & Chief Executive Officer

Director & Chief Executive Officer at Apogee Therapeutics, Inc., filing insider transactions on 2026-07-08.

Total Purchases

—

0 transactions

Total Sales

$2.7M

1 transaction

Companies Traded

1 total filings

Active Since

2026-07-08

Last: 2026-07-08

Companies

Apogee Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-07-08	APGE	Sale	20.0K	$133.63	$2.7M	996.0K	SEC ↗